These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2066995)

  • 1. Verapamil analogues with restricted molecular flexibility.
    Dei S; Romanelli MN; Scapecchi S; Teodori E; Chiarini A; Gualtieri F
    J Med Chem; 1991 Jul; 34(7):2219-25. PubMed ID: 2066995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil analogues with restricted molecular flexibility: synthesis and pharmacological evaluation of the four isomers of alpha-[1-[3-[N-[1- [2-(3,4-dimethoxyphenyl)ethyl]]-N-methylamino]cyclohexyl]]-alpha- isopropyl-3,4-dimethoxybenzene-acetonitrile.
    Dei S; Romanelli MN; Scapecchi S; Teodori E; Gualtieri F; Chiarini A; Voigt W; Lemoine H
    J Med Chem; 1993 Feb; 36(4):439-45. PubMed ID: 8474099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.
    Romanelli MN; Dei S; Scapecchi S; Teodori E; Gualtieri F; Budriesi R; Mannhold R
    J Comput Aided Mol Des; 1994 Apr; 8(2):123-34. PubMed ID: 8064330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAR studies in the field of calcium(II) antagonists. Effect of modifications at the tetrasubstituted carbon of verapamil-like compounds.
    Gualtieri F; Teodori E; Bellucci C; Pesce E; Piacenza G
    J Med Chem; 1985 Nov; 28(11):1621-8. PubMed ID: 4067990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
    Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
    Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of reduced diastereoisomeric and quaternary ammonium derivatives of calcium antagonistic (methylenedioxy)indenes on the isolated rat aorta.
    Witiak DT; Brumbaugh RJ; Heaslip RJ; Rahwan RG
    J Med Chem; 1982 Apr; 25(4):452-6. PubMed ID: 7069724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.
    Kimball SD; Hunt JT; Barrish JC; Das J; Floyd DM; Lago MW; Lee VG; Spergel SH; Moreland S; Hedberg SA
    Bioorg Med Chem; 1993 Oct; 1(4):285-307. PubMed ID: 8081860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
    Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.
    Fujita M; Ito S; Ota A; Kato N; Yamamoto K; Kawashima Y; Yamauchi H; Iwao J
    J Med Chem; 1990 Jul; 33(7):1898-905. PubMed ID: 2362267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective synthesis and pharmacological evaluation of a new type of verapamil analog with hypotensive and calcium antagonist activities.
    Holland HL; Gu JX; Orallo F; Camiña M; Fabeiro P; Willetts AJ
    Pharm Res; 1999 Feb; 16(2):281-7. PubMed ID: 10100315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoalkynyldithianes. A new class of calcium channel blockers.
    Adams TC; Dupont AC; Carter JP; Kachur JF; Guzewska ME; Rzeszotarski WJ; Farmer SG; Noronha-Blob L; Kaiser C
    J Med Chem; 1991 May; 34(5):1585-93. PubMed ID: 2033584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on Ca2+ channel antagonists. 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2- isopropylpentyl isothiocyanate, a chemoaffinity ligand derived from verapamil.
    Theodore LJ; Nelson WL; Zobrist RH; Giacomini KM; Giacomini JC
    J Med Chem; 1986 Sep; 29(9):1789-92. PubMed ID: 2427721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle.
    Nawrath H; Raschack M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1090-7. PubMed ID: 3656109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.
    Navidpour L; Miri R; Shafiee A
    Arzneimittelforschung; 2004; 54(9):499-504. PubMed ID: 15500195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel heterocyclic analogues of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
    Gubin J; de Vogelaer H; Inion H; Houben C; Lucchetti J; Mahaux J; Rosseels G; Peiren M; Clinet M; Polster P
    J Med Chem; 1993 May; 36(10):1425-33. PubMed ID: 8496910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
    Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.